cariprazine and its Impurities
Cariprazine is used to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder. Rights are currently owned by Gedeon Richter and Actavis.. Reference standards of Cariprazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below


1-((1r,4r)-4-(2-(4-(2,3-Dichloro-4-hydroxyphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-methylurea
1-((1r,4r)-4-(2-(4-(2,3-Dichloro-4-hydroxyphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-methylurea
Catalogue No.:PA 56 0481009
CAS :
1084891-94-0
Molecular Formula : C20H30Cl2N4O2
Molecular Weight : 429.39


4-(2,3-Dichlorophenyl)-N-((1r,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)piperazine-1-carboxamide
4-(2,3-Dichlorophenyl)-N-((1r,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)piperazine-1-carboxamide
Catalogue No.:PA 56 0481023
CAS :
NA
Molecular Formula : C29H37Cl4N5O
Molecular Weight : 613.45


Carbamic acid, N-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-, ethyl Ester
Carbamic acid, N-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-, ethyl Ester
Catalogue No.:PA 56 0481024
CAS :
1957145-61-7
Molecular Formula : C21H31Cl2N3O2
Molecular Weight : 428.4


1-((1r,4r)-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-3,3-dimethyl-1-nitrosourea
1-((1r,4r)-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-3,3-dimethyl-1-nitrosourea
Catalogue No.:PA 56 0481033
CAS :
NA
Molecular Formula : C21H31Cl2N5O2
Molecular Weight : 456.41


1-(2,3-Dichlorophenyl)-4-(2-((1r,4r)-4-(3,3-dimethylureido)cyclohexyl)ethyl)piperazine 1-oxide
1-(2,3-Dichlorophenyl)-4-(2-((1r,4r)-4-(3,3-dimethylureido)cyclohexyl)ethyl)piperazine 1-oxide
Catalogue No.:PA 56 0481038
CAS :
NA
Molecular Formula : C21H32Cl2N4O2
Molecular Weight : 443.41